In this article, we will discuss 5 best multi-bagger stocks to buy now. To read the detailed analysis of the current market and these stocks, go directly to 10 Best Multi-Bagger Stocks to Buy Now.
5. Scorpio Tankers Inc. (NYSE:STNG)
12-Month Returns as of August 2: 147.10%
Scorpio Tankers Inc. (NYSE:STNG) is an international shipping company for refined petroleum products. At the end of Q2 2022, Scorpio Tankers Inc. (NYSE:STNG) reported an EPS of $3.13, outperforming the estimates by $0.21. The revenue for the quarter was $405.07, representing a 190.5% growth on a YoY basis. Furthermore, the company exited the quarter with $449.5 million in unrestricted cash and cash equivalents.
On July 28, Scorpio Tankers Inc. (NYSE:STNG) declared a dividend of $0.10, to be paid out on September 15 to the shareholders on record as of August 11. Furthermore, the company also declared that it has repurchased 367,861 shares, valued at around $10.73 million in July. As of August 2, the company has a dividend yield of 1.04% with an annualized dividend payout of $0.4.
4. Antero Resources Corporation (NYSE:AR)
12-Month Returns as of August 2: 179.73%
Antero Resources Corporation (NYSE:AR) is a hydro-carbon exploration company with all of its reserves in the Appalachian Basin. The company’s reserves contain natural gas, ethane, natural gas liquids, and petroleum. As of August 2, the company stock made a giant leap of almost 179.73% in the last 12 months.
Antero Resources Corporation (NYSE:AR) announced its Q2 2022 results on July 27. The company reported a non-GAAP net income of $563 million. The company generated a revenue of $2.2 billion representing a 349.5% YoY growth and outperforming analyst estimates by $380 million. Furthermore, net cash provided by operating activities was $923 million and non-GAAP FCF of $664 million was recorded. The company also repurchased stock worth $247 million and reduced its total debt by $383 million.
On July 19, Mizuho analyst Vincent Lovaglio lowered the price target of Antero Resources Corporation (NYSE:AR) to $53 from 59, while Truist analyst Neal Dingmann raised the firm’s price target to $58 from $50. However, both of the analysts maintained a Buy rating on the company shares.
3. Lantheus Holdings, Inc. (NASDAQ:LNTH)
12-Month Returns as of August 2: 186.13%
Lantheus Holdings, Inc. (NASDAQ:LNTH) is a global diagnostics and research company headquartered in Massachusetts. It manufactures products to assist medical practitioners in the diagnosis and treatment of heart, cancer, and several other diseases. On May 9, B. Riley analyst Justin Walsh initiated Lantheus Holdings, Inc. (NASDAQ:LNTH)’s coverage with a Buy rating and a price target of $91. Walsh calls the company a “leading diagnostic imaging and nuclear medicine company”. Moreover, he expects FY2022 results to be doubled compared to the last year, owing to its prostate cancer imaging agent Pylarify’s launch.
Investment portfolios showed a fairly positive sentiment towards Lantheus Holdings, Inc. (NASDAQ:LNTH) in the first quarter of 2022. According to the Insider Monkey database, 35 hedge funds were bullish on the company with a combined stake value of $523.52 million. In the previous quarter, Lantheus Holdings, Inc. (NASDAQ:LNTH) was a part of 15 hedge fund portfolios.
Here is what Clearbridge Investments had to say about Lantheus Holdings, Inc. (NASDAQ:LNTH) in its Q1 2022 investor letter:
“While companies with immature business models and no profits exist throughout the market, there are certain sectors where they congregate more easily, such as health care. As access to cheap capital recedes, however, many of these specialty drug and biotech companies will likely find it challenging to dismiss long periods of unprofitability. While we have had limited exposure in the sector, our focus on finding high-quality companies at attractive valuations has yielded positive results. For example, Lantheus Holdings (NASDAQ:LNTH) is a global leader in medical diagnostic imaging whose core business suffered during the COVID-19 pandemic due to a dramatic decline in hospital visits. As hospitals return to a level of normalcy, Lantheus’s core business has rebounded. Additionally, in late 2021 the company received approval for its new radio-pharmacological drug, Pylarify, for the treatment of prostate cancer, and initial sales have been well ahead of expectations. We believe it has a strong future in oncology diagnosis and treatment. As a result, Lantheus was our strongest individual performer for the first quarter.”
2. CONSOL Energy Inc. (NYSE:CEIX)
12-Month Returns as of August 2: 188.35%
CONSOL Energy Inc. (CEIX:NYSE) is a Pennsylvania-based energy company primarily focusing on coal. Most of the company’s coal is used for electricity generation. In Q1 2022, the company recorded a free cash flow of $119 billion and paid $39 million of it towards debt reduction. For FY2022, Wall Street analysts estimate an EBITDA of $740 million and $381 million in free cash flow. Furthermore, the company expects to sell 23 to 25 million tonnes of coal by the end of the year.
According to the Insider Monkey database, CONSOL Energy Inc. (CEIX:NYSE) was a part of 22 investment portfolios, compared to 15 in the previous quarter. In Q1, Greenlight Capital held the top position in the company with shares worth $55.49 million.
On May 5, B. Riley analyst Lucas Pipes reiterated a Buy rating on CONSOL Energy Inc. (CEIX)’s and raised his price target from $46 to $63. He also expects an expanding order book for 2023.
1. Target Hospitality Corp. (NASDAQ:TH)
12-Month Returns as of August 2: 309.07%
Target Hospitality Corp. (NASDAQ:TH) is an American speciality rental company. The company focuses on workforce lodging and mobile crew camps along with catering, security, and transportation. On July 8, following the announcement of a new government contract in July, the company raised its revenue guidance by 53%. Since the announcement, Target Hospitality Corp. (NASDAQ:TH) stock has been up by over 177.16% in the last 30 days.
Oppenheimer analyst Scott Schneeberger maintained an Outperform rating on Target Hospitality Corp. (NASDAQ:TH)’s shares and raised his price target on the firm to $18 from $9. The analyst revised his price target in light of the contract extension of the West Texas government facility. The contract was extended to May 15, 2023, but Scott Schneeberger believes that it will continue for much longer.
As of the first quarter of 2022, 27 hedge funds were bullish on Target Hospitality Corp. (NASDAQ:TH)’s shares with a combined stake value of $223.1 million, compared to the previous quarter’s $86.6 million investment by 24 hedge funds. Private Capital Management held the most prominent stake in Q1 2022, with almost 5.4 million shares worth $32.28 million.
You can also take a look at 10 Crypto Companies Hit By the Recent Crash and 10 Buy-The-Dip Restaurant Stocks to Invest In Now.
